stacie dusetzina has been watching all of this closely.ssor of health policy and cancer research at vanderbilt university school of medicine. stacie, explain why his announcement is a big deal, and how will it impact of those who take those specific 10 medications? , for example, so -- prof. dusetzina: so, it is a really big deal, because when me medicare part d was first enacted, medicare was banned from negotiate drug prices directly, so this is the first time medicare has been able to negotiate for individual drug prices across all medicare beneficiaries also it is really an important step. stephanie: now, for people who take these drugs on the list, some of them will see direct benefits in their prices going down, by the time new prices are implement it in 2026. that includes anybody who is paying a deductible or a coinsurance, a percentage of the drug's price, so especially for many of the drugs on the list that are somewhat lower prices, quite disease medications that are sold every month, patients may actually see the prices go down